Amundi Asset Management US’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-7,000
| Closed | -$167K | – | 1680 |
|
|
2019
Q4 | $167K | Hold |
7,000
| – | – | ﹤0.01% | 1488 |
|
|
2019
Q3 | $188K | Buy |
7,000
+1,500
| +27% | +$40.3K | ﹤0.01% | 1456 |
|
|
2019
Q2 | $149K | Sell |
5,500
-26,413
| -83% | -$716K | ﹤0.01% | 1496 |
|
|
2019
Q1 | $1.11M | Sell |
31,913
-487,287
| -94% | -$16.9M | ﹤0.01% | 1175 |
|
|
2018
Q4 | $10.1K | Buy |
519,200
+67,300
| +15% | +$1.31K | 0.01% | 653 |
|
|
2018
Q3 | $12M | Buy |
451,900
+248,800
| +123% | +$6.63M | 0.02% | 686 |
|
|
2018
Q2 | $7.67M | Buy |
203,100
+28,241
| +16% | +$1.07M | 0.01% | 808 |
|
|
2018
Q1 | $5.71M | Buy |
174,859
+66,900
| +62% | +$2.18M | 0.01% | 822 |
|
|
2017
Q4 | $5.26M | Buy |
+107,959
| New | +$5.26M | 0.01% | 827 |
|